Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT) HY Meltzer, L Alphs, AI Green, AC Altamura, R Anand, A Bertoldi, ... Archives of general psychiatry 60 (1), 82-91, 2003 | 1637 | 2003 |
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. G Chouinard, B Jones, G Remington, D Bloom, D Addington, ... Journal of clinical psychopharmacology 13 (1), 25-40, 1993 | 1225 | 1993 |
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials SR Marder, JM Davis, G Chouinard J Clin Psychiatry 58 (12), 538-546, 1997 | 900 | 1997 |
Extrapyramidal rating scale G Chouinard Can. J. Neurol. Sci. 7, 233, 1980 | 880 | 1980 |
Manual for the extrapyramidal symptom rating scale (ESRS) G Chouinard, HC Margolese Schizophrenia research 76 (2-3), 247-265, 2005 | 426 | 2005 |
Placebo-controlled study of gabapentin treatment of panic disorder AC Pande, MH Pollack, J Crockatt, M Greiner, G Chouinard, RB Lydiard, ... Journal of clinical psychopharmacology 20 (4), 467-471, 2000 | 418 | 2000 |
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics G Chouinard, BD Jones Am J Psychiatry 137 (1), 16-21, 1980 | 411 | 1980 |
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics G Chouinard, BD Jones Am J Psychiatry 137 (1), 16-21, 1980 | 411 | 1980 |
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound G Chouinard Journal of Clinical Psychiatry 65, 7-12, 2004 | 403 | 2004 |
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder J Greist, G Chouinard, E DuBoff, A Halaris, SW Kim, L Koran, M Liebowitz, ... Archives of General Psychiatry 52 (4), 289-295, 1995 | 401 | 1995 |
Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. FW Reimherr, G Chouinard, CK Cohn, JO Cole, TM Itil, YD LaPierre, ... The Journal of clinical psychiatry 51, 18-27, 1990 | 344 | 1990 |
Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients AM Ghadirian, G Chouinard, L Annable The Journal of nervous and mental disease 170 (8), 463-467, 1982 | 337 | 1982 |
Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study G Chouinard, L Annable, R Fontaine, L Solyom Psychopharmacology 77, 229-233, 1982 | 333 | 1982 |
Neuroleptic-induced supersensitivity psychosis. G Chouinard, BD Jones, L Annable The American journal of psychiatry, 1978 | 268 | 1978 |
Antimanic effect of clonazepam. G Chouinard, SN Young, L Annable Biological psychiatry 18 (4), 451-466, 1983 | 265 | 1983 |
Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial Y Dion, L Annable, P Sandor, G Chouinard Journal of clinical psychopharmacology 22 (1), 31-39, 2002 | 261 | 2002 |
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The lancet respiratory medicine 7 (1), 46-59, 2019 | 250 | 2019 |
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment R Fontaine, G Chouinard, L Annable Am J Psychiatry 141 (7), 848-852, 1984 | 233 | 1984 |
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. G Chouinard, W Goodman, J Greist, M Jenike, S Rasmussen, K White, ... Psychopharmacology bulletin 26 (3), 279-284, 1990 | 231 | 1990 |
A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder JH Greist, JW Jefferson, KA Kobak, G Chouinard, E DuBoff, A Halaris, ... International clinical psychopharmacology 10 (2), 57-66, 1995 | 215 | 1995 |